Columbia, SC, October 5, 2007 – Collexis (OTCBB: CLXS), a leading developer of High Definition Search and Discovery software, is pleased to report the distinguished Wageningen Universiteit Library has just upgraded its Collexis Search software to Collexis High Definition Search 6.0. The reason for the upgrade is based on extended features and usability.
Hubert Krekels, WUR Libraries Head of Documentation & Publication Services stated, “Using Collexis technology virtually guarantees easy retrieval on agricultural and life science searches, as well as finding experts based on validated profiles. The main goal of utilizing this upgrade is its ability to help us identify WUR-employed experts. We also consider Collexis to be a strategic part of the future developments of the WUR Library.”
The WUR Library will be integrating the Collexis Search software on a publicly available website and will roll it out to other departments and systems within Wageningen UR.
Bill Kirkland, Collexis CEO, commented, “For over four years now Collexis and the WUR Library have had a strong relationship. WUR has contributed to Collexis as a reference and proved to be a strong partner in agricultural domains. We are proud to say WUR has enforced its trust in Collexis by migrating to our latest 6.0 version in order to take advantage of new features and options.”
Collexis High Definition Search software is used by other eminent university libraries, including: Erasmus University Library, Technical University Delft Library, Mayo Clinic Libraries and Johns Hopkins.
The WUR Library manages over 120,000 publications and links to their authors. The Collexis High Definition Search 6.0 enables the user to search these publications via full text, abstract and title. This enables the researcher to find the most appropriate experts and acquire a direct link that provides personal data on them.
Collexis High Definition Search 6.0 enables extraordinary knowledge retrieval and discovery quickly and accurately by utilizing fingerprinting technology. The Collexis Fingerprint empowers users to immediately identify and search for documents, experts, trends and new discoveries more quickly and accurately than conventional search engines.
Collexis Holdings, Inc.
Collexis Holdings, Inc., a global knowledge discovery company since 1999, is headquartered in Columbia, South Carolina (USA) with two subsidiaries; Collexis Inc. in Columbia, South Carolina, USA and Collexis, B.V. in Geldermalsen, The Netherlands. Collexis patented technology builds conceptual profiles of text, called Fingerprints, from documents, websites, e-mails and other digitized content and matches them with a comprehensive list of pre-defined “fingerprinted” concepts to make research results more relevant and efficient. This matching of concepts eliminates the ambiguity and lack of priority associated with word searches. The results are often described as ”finding needles in many haystacks.” Through this novel approach, Collexis can build unique applications to search, index and aggregate information as well as prioritize, trend and predict data based on sources in multiple industries without the limitations of language or dialect. Representative clients include the NIH, Johns Hopkins, Erasmus University Rotterdam, the Wellcome Trust, Harvard and the University of South Carolina to name a few.
Collexis shares of common stock are traded under the symbol CLXS on the OTC Bulletin Board (OTC BB).
For more information visit www.collexis.com.
This press release contains forward-looking statements. Such statements are valid only as of today, and we disclaim any obligation to update this information. These statements are subject to known and unknown risks and uncertainties that may cause actual future experience and results to differ materially from the statements made. These statements are based on our current beliefs and expectations as to future outcomes. Factors that could affect future performance include business and economic trends, the ability to continue funding operating losses, fluctuations in operating results, continued success in developing our research software and other risk factors as disclosed in our public filings with the Securities and Exchange Commission.